Investors Slam Inovio's Bid To Duck COVID-19 Vaccine Suit
Biotechnology firm Inovio Pharmaceuticals Inc. and a cohort of company executives shouldn't be allowed to shake off a consolidated class action alleging they misled the public about a coronavirus vaccine they...To view the full article, register now.
Already a subscriber? Click here to view full article